BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 33909599)

  • 1. Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma.
    Ruan GT; Wang S; Zhu LC; Liao XW; Wang XK; Liao C; Yan L; Xie HL; Gong YZ; Gan JL; Gao F
    Aging (Albany NY); 2021 Apr; 13(9):12565-12586. PubMed ID: 33909599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma.
    Gong YZ; Ruan GT; Liao XW; Wang XK; Liao C; Wang S; Gao F
    Oncol Rep; 2019 Sep; 42(3):923-936. PubMed ID: 31322253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
    Huang W; Liu Z; Li Y; Liu L; Mai G
    J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
    Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
    Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
    Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
    Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
    Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
    Front Immunol; 2021; 12():665002. PubMed ID: 34367132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
    Jin L; Li C; Liu T; Wang L
    Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent prognostic genes and mechanism investigation for colon cancer.
    Li C; Shen Z; Zhou Y; Yu W
    Biol Res; 2018 Apr; 51(1):10. PubMed ID: 29653552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification prognosis-associated immune genes in colon adenocarcinoma.
    Miao Y; Wang J; Ma X; Yang Y; Mi D
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma.
    Zhao QQ; Jiang C; Gao Q; Zhang YY; Wang G; Chen XP; Wu SB; Tang J
    J Cell Physiol; 2020 May; 235(5):4902-4912. PubMed ID: 31709538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ULBP2 is a biomarker related to prognosis and immunity in colon cancer.
    Yang X; Su X; Wang Z; Yu Y; Wu Z; Zhang D
    Mol Cell Biochem; 2023 Oct; 478(10):2207-2219. PubMed ID: 36633827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INHBA is a prognostic predictor for patients with colon adenocarcinoma.
    Li X; Yu W; Liang C; Xu Y; Zhang M; Ding X; Cai X
    BMC Cancer; 2020 Apr; 20(1):305. PubMed ID: 32293338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis.
    Ruan GT; Xie HL; Zhu LC; Ge YZ; Yan L; Liao C; Gong YZ; Shi HP
    Front Genet; 2022; 13():762514. PubMed ID: 35211154
    [No Abstract]   [Full Text] [Related]  

  • 14. Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms.
    Chen S; Cao GD; Wei W; Yida L; Xiaobo H; Lei Y; Ke C; Chen B; Xiong MM
    World J Surg Oncol; 2020 Jun; 18(1):146. PubMed ID: 32600423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers.
    Li F; Zhou J; Li Z; Zhang L
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33646276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma.
    Yu J; Yang K; Zheng J; Sun X; Zhao W
    Gene; 2022 Jan; 808():145990. PubMed ID: 34624456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma.
    Yang M; He H; Peng T; Lu Y; Yu J
    Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatially aware graph neural networks and cross-level molecular profile prediction in colon cancer histopathology: a retrospective multi-cohort study.
    Ding K; Zhou M; Wang H; Zhang S; Metaxas DN
    Lancet Digit Health; 2022 Nov; 4(11):e787-e795. PubMed ID: 36307192
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Liu L; Jia S; Jin X; Zhu S; Zhang S
    DNA Cell Biol; 2021 Sep; 40(9):1158-1166. PubMed ID: 34415792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-1249 targets four-jointed box kinase 1 and reduces cell proliferation, migration and invasion of colon adenocarcinoma.
    Dang W; Zhu Z
    J Gene Med; 2020 Jul; 22(7):e3183. PubMed ID: 32159255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.